65,437 trials
Plasmodium Falciparum Malaria
Primary: Number of Subjects Reporting Solicited Adverse Events During the 7-day Surveillance Period After the First Vaccination — 0; 5; 0; 12 Participants
Gastric Cancer
Primary: Percentage of Participants With Objective Response (Objective Response Rate) — 32.1; 67.9 percentage of responders
Dysfunctional Central Venous Access Catheters
Primary: Percentage of Patients Who Had Restoration of Central Venous Catheter (CVC) Function Following a Single Administration of Study Drug — 23.4; 60.0 percentage of…
Metastatic Breast Cancer
Primary: Number of Participants With a Dose Limiting Toxicity (DLT) — 1; 1; 2; 1 Participants
Smoking Cessation
Primary: Change From Baseline in the Profile of Mood States (POMS): Total Mood Disturbance (TMD) — 0.06; -0.66; 0.30; -0.17 scores on a scale
Coronary Artery Disease
Primary: Inhibition of Platelet Aggregation (IPA) to 20 Micromolar (μM) Adenosine Diphosphate (ADP) at 6 Hours After the Loading Dose — 74.81; 31.77 percent inhibition — p=<0.0001
Diabetic Foot Ulcers (DFU) · Venous Stasis Ulcers (VSU)
Primary: Decrease in Wound Area From Baseline After 12 Weeks of Treatment or Until Wound Closure, Whichever Occurred First. — 1.3; 3.6 cm2
Infections, Papillomavirus
Primary: Number of Seroconverted Subjects for Anti-human Papilloma Virus 16 (Anti-HPV-16) and Anti-human Papilloma Virus 18 (Anti-HPV-18) Antibodies, in Women 15 to 25 Years of…
Temporomandibular Disorders
Primary: Change From Baseline In Craniomandibular Index (CMI) Scores At 3 Months (In A Scale) — .23; .20 Units on a scale — p=<0.0096
Constipation
Primary: Mean Number of Complete Spontaneous Bowel Movements (CSBMs) Per Week Over the 4 Weeks Treatment Period — 1.9; 5.2 CSBMs per week — p=<0.0001
Helicobacter Infections
Primary: Helicobacter Pylori Eradication Confirmed by Urea Breath Test — 166; 112 Participants
Tetanus · Acellular Pertussis · Diphtheria
Primary: Number of Subjects With Antibody Concentration Against Vaccine Antigens, Above a Protocol Defined Cut-off Value — 729; 374; 836; 428 subjects
Pulmonary Embolism
Primary: Percentage of Participants With Clinical Success — 88 Percent of Participants
Patellofemoral Pain Syndrome
Primary: Visual Analog Pain Scale (Describing Worst Pain Felt During the Past Week) — 4.5; 4.2 centimeter
Cataract · Floppy Iris Syndrome
Primary: Corneal Endothelial Cell Loss — 9.85; -3.68 Percent change